Page last updated: 2024-11-08

serine and Psychoses

serine has been researched along with Psychoses in 28 studies

Serine: A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from GLYCINE or THREONINE. It is involved in the biosynthesis of PURINES; PYRIMIDINES; and other amino acids.
serine : An alpha-amino acid that is alanine substituted at position 3 by a hydroxy group.

Research Excerpts

ExcerptRelevanceReference
"Schizophrenia is associated with deficits in cortical plasticity that affect sensory brain regions and lead to impaired cognitive performance."6.82Neurophysiological mechanisms of cortical plasticity impairments in schizophrenia and modulation by the NMDA receptor agonist D-serine. ( Ahissar, M; Beggel, O; Epstein, ML; Javitt, DC; Kantrowitz, JT; Lehrfeld, JM; Lehrfeld, NP; Parker, E; Reep, J; Revheim, N; Rohrig, S; Silipo, G, 2016)
"Subjects had DSM-IV schizophrenia or schizoaffective disorder and were inpatients or outpatients stabilized on antipsychotics, with persistent negative symptoms."6.77A multicenter, add-on randomized controlled trial of low-dose d-serine for negative and cognitive symptoms of schizophrenia. ( Abramovich, Y; Amital, D; Davidson, M; Doron, A; Gershon, AA; Heresco-Levy, U; Javitt, DC; Konas, S; Levkovitz, Y; Liba, D; Mashiach, M; Teitelbaum, A; Weiser, M; Werbeloff, N; Zimmerman, Y, 2012)
"Plasma serine levels (PSL) in a group of patients with the diagnosis of major or atypical psychoses were significantly higher than in patients with nonpsychotic diagnoses or nonpatient controls."3.67Serine metabolism and psychosis. ( Mott, J; Sherman, AD; Waziri, R; Wilcox, J, 1984)
"It was investigated whether an increased demand for glycine, as postulated to occur in patients who have suffered from episodic psychoses accompanied by multiple perceptual distortions, could evoke psychotic reactions."3.66Serine and glycine-induced catalepsy in porphyric rats: an animal model for psychosis? ( Bruinvels, J; Pepplinkhuizen, L; Schouten, MJ; Wilson, JH, 1983)
"Schizophrenia is associated with deficits in cortical plasticity that affect sensory brain regions and lead to impaired cognitive performance."2.82Neurophysiological mechanisms of cortical plasticity impairments in schizophrenia and modulation by the NMDA receptor agonist D-serine. ( Ahissar, M; Beggel, O; Epstein, ML; Javitt, DC; Kantrowitz, JT; Lehrfeld, JM; Lehrfeld, NP; Parker, E; Reep, J; Revheim, N; Rohrig, S; Silipo, G, 2016)
"Subjects had DSM-IV schizophrenia or schizoaffective disorder and were inpatients or outpatients stabilized on antipsychotics, with persistent negative symptoms."2.77A multicenter, add-on randomized controlled trial of low-dose d-serine for negative and cognitive symptoms of schizophrenia. ( Abramovich, Y; Amital, D; Davidson, M; Doron, A; Gershon, AA; Heresco-Levy, U; Javitt, DC; Konas, S; Levkovitz, Y; Liba, D; Mashiach, M; Teitelbaum, A; Weiser, M; Werbeloff, N; Zimmerman, Y, 2012)
"Haloperidol-treated rats were divided into groups of DSP rats and non-DSP rats based on locomotion data."1.46Alterations in glutamatergic signaling in the brain of dopamine supersensitivity psychosis and non-supersensitivity psychosis model rats. ( Fujita, Y; Hashimoto, K; Iyo, M; Kanahara, N; Nakata, Y; Niitsu, T; Oda, Y; Oishi, K; Shirayama, Y; Takase, M, 2017)

Research

Studies (28)

TimeframeStudies, this research(%)All Research%
pre-19908 (28.57)18.7374
1990's7 (25.00)18.2507
2000's6 (21.43)29.6817
2010's7 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Garip, B1
Kayir, H1
Oda, Y1
Fujita, Y1
Oishi, K1
Nakata, Y1
Takase, M1
Niitsu, T1
Kanahara, N1
Shirayama, Y1
Hashimoto, K1
Iyo, M1
Sasabe, J1
Suzuki, M1
Li, C1
Wang, A1
Wang, C1
Ramamurthy, J1
Zhang, E1
Guadagno, E1
Trakadis, Y1
Pinacho, R1
Saia, G1
Fusté, M1
Meléndez-Pérez, I1
Villalta-Gil, V1
Haro, JM1
Gill, G1
Ramos, B1
Kantrowitz, JT1
Epstein, ML1
Beggel, O1
Rohrig, S1
Lehrfeld, JM1
Revheim, N1
Lehrfeld, NP1
Reep, J1
Parker, E1
Silipo, G1
Ahissar, M1
Javitt, DC2
Weiser, M1
Heresco-Levy, U1
Davidson, M1
Werbeloff, N1
Gershon, AA1
Abramovich, Y1
Amital, D1
Doron, A1
Konas, S1
Levkovitz, Y1
Liba, D1
Teitelbaum, A1
Mashiach, M1
Zimmerman, Y1
Sumiyoshi, T1
Anil, AE1
Jin, D1
Jayathilake, K1
Lee, M1
Meltzer, HY2
Shizuka, K1
Yoneda, H1
Bakker, PR1
van Harten, PN1
van Os, J1
DeRosse, P1
Hodgkinson, CA1
Lencz, T1
Burdick, KE1
Kane, JM1
Goldman, D2
Malhotra, AK2
Verhoeven, WM1
Van Ravenswaaij-Arts, CM1
De Leeuw, N1
Fekkes, D4
Van der Heijden, FM1
Egger, JI1
Tuinier, S1
Pepplinkhuizen, L6
Bruinvels, J5
Blom, W1
Moleman, P1
Waziri, R6
Wilcox, J2
Sherman, AD2
Mott, J3
Wilson, R1
Schouten, MJ1
Wilson, JH1
Verheij, R1
Brown, FW1
Devor, EJ1
Bode, WT1
Zijlstra, FJ1
Sasaki, T1
Macciardi, FM1
Badri, F1
Verga, M1
Lieberman, J1
Howard, A1
Bean, G1
Joffe, RT1
Hudson, CJ1
Kennedy, JL1
Ozaki, N1
Rooney, W1
Clifton, A1
Buchanan, RW1
Breier, A1
Pickar, D1
Serretti, A1
Lattuada, E1
Lorenzi, C1
Lilli, R1
Smeraldi, E1
Sherman, A1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
D-serine and Cognitive Remediation in Schizophrenia: Open Label Pilot[NCT02156908]Phase 28 participants (Actual)Interventional2014-08-31Completed
D-Serine Adjuvant Pharmacotherapy for the Treatment of Schizophrenia[NCT00138775]Phase 2200 participants Interventional2004-10-31Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Mismatch Negativity (MMN)

"An MMN event is evoked by a discernible change in the pitch of a repetitive auditory stimulation. The stronger the response to a difference (i.e., the more negative the amplitude of the MMN), the better the outcome.~MMN was obtained to pitch deviant stimuli pre-post auditory plasticity training, utilizing deviants to the same base frequencies as the auditory plasticity sessions, (i.e. 500, 1000, and 2000 Hz), with ~10 minutes of each base frequency. MMN will be conducted at baseline and after the final session. Reported outcome is change in MMN between baseline and final within session." (NCT02156908)
Timeframe: 3 weeks

Interventionmicro volts (Mean)
D-serine.086
no Intervention0.31

Tone Matching Threshold

Change tone matching threshold (the percent difference in pitch of two consecutively played tones that can be distinguished), higher numbers represent better outcomes. D-serine outcomes are for 2 consecutive D-serine sessions (NCT02156908)
Timeframe: three weeks

Interventionpercentage of difference in pitch (Mean)
D-serine11
No Intervention2.3

Reviews

4 reviews available for serine and Psychoses

ArticleYear
Distinctive Roles of D-Amino Acids in the Homochiral World: Chirality of Amino Acids Modulates Mammalian Physiology and Pathology.
    The Keio journal of medicine, 2019, Mar-25, Volume: 68, Issue:1

    Topics: Amino Acids; Animals; Archaea; Bacteria; D-Aspartic Acid; Endocrine System; Humans; Immunity, Innate

2019
Metabolomics in patients with psychosis: A systematic review.
    American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics, 2018, Volume: 177, Issue:6

    Topics: 3-Hydroxybutyric Acid; Aspartic Acid; Biomarkers; Bipolar Disorder; Creatine; Female; Glutamic Acid;

2018
[Outcome of genetic studies on atypical psychoses].
    Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica, 2004, Volume: 106, Issue:3

    Topics: Chromosomes, Human, Pair 1; Cysteine; Genetic Predisposition to Disease; Haplotypes; Humans; Membran

2004
The neurobiology of late-life psychosis.
    Critical reviews in neurobiology, 1993, Volume: 7, Issue:3-4

    Topics: Aged; Brain; Dopamine; Electroencephalography; Evoked Potentials; Humans; Magnetic Resonance Imaging

1993

Trials

3 trials available for serine and Psychoses

ArticleYear
Neurophysiological mechanisms of cortical plasticity impairments in schizophrenia and modulation by the NMDA receptor agonist D-serine.
    Brain : a journal of neurology, 2016, Volume: 139, Issue:Pt 12

    Topics: Adult; Auditory Perceptual Disorders; Brain Waves; Cohort Studies; Evoked Potentials, Auditory; Exci

2016
A multicenter, add-on randomized controlled trial of low-dose d-serine for negative and cognitive symptoms of schizophrenia.
    The Journal of clinical psychiatry, 2012, Volume: 73, Issue:6

    Topics: Adult; Antipsychotic Agents; Cognition; Double-Blind Method; Drug Therapy, Combination; Female; Huma

2012
Plasma glycine and serine levels in schizophrenia compared to normal controls and major depression: relation to negative symptoms.
    The international journal of neuropsychopharmacology, 2004, Volume: 7, Issue:1

    Topics: Adult; Chromatography, High Pressure Liquid; Depressive Disorder, Major; Female; Glycine; Humans; Ma

2004

Other Studies

21 other studies available for serine and Psychoses

ArticleYear
Alteration in NMDAR-related amino acids in first episode psychosis.
    Synapse (New York, N.Y.), 2019, Volume: 73, Issue:11

    Topics: Asparagine; Chromatography, Liquid; Female; Glutamic Acid; Glutamine; Humans; Hydroxyproline; Male;

2019
Alterations in glutamatergic signaling in the brain of dopamine supersensitivity psychosis and non-supersensitivity psychosis model rats.
    Psychopharmacology, 2017, Volume: 234, Issue:20

    Topics: Animals; Antipsychotic Agents; Brain; Dopamine; Glutamate Decarboxylase; Glutamic Acid; Glutamine; H

2017
Phosphorylation of transcription factor specificity protein 4 is increased in peripheral blood mononuclear cells of first-episode psychosis.
    PloS one, 2015, Volume: 10, Issue:4

    Topics: Adolescent; Adult; Animals; Antipsychotic Agents; Benzodiazepines; Cells, Cultured; Cross-Sectional

2015
Antipsychotic-induced tardive dyskinesia and the Ser9Gly polymorphism in the DRD3 gene: a meta analysis.
    Schizophrenia research, 2006, Volume: 83, Issue:2-3

    Topics: Alleles; Antipsychotic Agents; Chi-Square Distribution; Dyskinesia, Drug-Induced; Female; Glycine; H

2006
Disrupted in schizophrenia 1 genotype and positive symptoms in schizophrenia.
    Biological psychiatry, 2007, May-15, Volume: 61, Issue:10

    Topics: Cysteine; Delusions; Genetic Carrier Screening; Genetic Predisposition to Disease; Genotype; Halluci

2007
Disturbed serine metabolism and psychosis in a patient with a de novo translocation (2;10)(p23;q22.1).
    Genetic counseling (Geneva, Switzerland), 2006, Volume: 17, Issue:4

    Topics: Adult; Chromosomes, Human, Pair 10; Chromosomes, Human, Pair 2; DiGeorge Syndrome; Female; Humans; H

2006
Schizophrenia-like psychosis caused by a metabolic disorder.
    Lancet (London, England), 1980, Mar-01, Volume: 1, Issue:8166

    Topics: Adolescent; Adult; Antipsychotic Agents; Diagnosis, Differential; Female; Glycine; Humans; Porphyria

1980
Serine metabolism and psychosis.
    Psychiatry research, 1984, Volume: 12, Issue:2

    Topics: Adult; Antipsychotic Agents; Brief Psychiatric Rating Scale; Diet; Glycine; Glycine Hydroxymethyltra

1984
Plasma serine to cysteine ratio as a biological marker for psychosis.
    The British journal of psychiatry : the journal of mental science, 1983, Volume: 143

    Topics: Adolescent; Adult; Chromatography, Gas; Cysteine; Female; Humans; Male; Middle Aged; Psychotic Disor

1983
Serine and glycine-induced catalepsy in porphyric rats: an animal model for psychosis?
    Pharmacology, biochemistry, and behavior, 1983, Volume: 19, Issue:2

    Topics: Allylisopropylacetamide; Aminolevulinic Acid; Animals; Catalepsy; Disease Models, Animal; Glycine; H

1983
Abnormal plasma levels of serine, methionine, and taurine in transient acute polymorphic psychosis.
    Psychiatry research, 1994, Volume: 51, Issue:1

    Topics: Adult; Bipolar Disorder; Diagnosis, Differential; Female; Humans; Male; Methionine; Middle Aged; Psy

1994
A familial/genetic study of plasma serine and glycine concentrations.
    Biological psychiatry, 1993, Aug-15, Volume: 34, Issue:4

    Topics: Dopamine; Female; gamma-Aminobutyric Acid; Glucose; Glutamates; Glycine; Humans; Internal-External C

1993
Eicosanoid and amino acid metabolism in transient acute psychoses with psychedelic symptoms.
    Prostaglandins, leukotrienes, and essential fatty acids, 1996, Volume: 54, Issue:4

    Topics: Adult; Female; Glutathione; Humans; Male; Methionine; Prostaglandins E; Psychotic Disorders; Serine;

1996
No evidence for association of dopamine D2 receptor variant (Ser311/Cys311) with major psychosis.
    American journal of medical genetics, 1996, Jul-26, Volume: 67, Issue:4

    Topics: Adult; Age of Onset; Amino Acid Sequence; Bipolar Disorder; Cysteine; Delusions; Female; Genetic Var

1996
Clozapine response and the 5HT2C Cys23Ser polymorphism.
    Neuroreport, 1996, Sep-02, Volume: 7, Issue:13

    Topics: Alleles; Antipsychotic Agents; Base Sequence; Clozapine; Cysteine; DNA Primers; Female; Genetic Carr

1996
Dopamine receptor D2 Ser/Cys 311 variant is associated with delusion and disorganization symptomatology in major psychoses.
    Molecular psychiatry, 2000, Volume: 5, Issue:3

    Topics: Adult; Amino Acid Substitution; Bipolar Disorder; Cysteine; Depressive Disorder; Female; Genetic Var

2000
Changes in serine metabolism by a serum factor present in a group of episodic psychotic patients.
    Biological psychiatry, 1991, Nov-15, Volume: 30, Issue:10

    Topics: Amino Acids; Cell Line; Cells, Cultured; Cystathionine beta-Synthase; Fibroblasts; Glycine Hydroxyme

1991
Drug effects on serine metabolism in psychiatric patients.
    Psychiatry research, 1986, Volume: 18, Issue:2

    Topics: Antipsychotic Agents; Glycine Hydroxymethyltransferase; Humans; Mental Disorders; Psychotic Disorder

1986
Serine, glycine and carbohydrates in schizoaffective disorders.
    Bibliotheca nutritio et dieta, 1986, Issue:38

    Topics: Amino Acids; Dietary Carbohydrates; Glycine; Humans; Psychotic Disorders; Reference Values; Serine

1986
Serine metabolism, psychosis, and coeliac disease.
    Biological psychiatry, 1985, Volume: 20, Issue:1

    Topics: Celiac Disease; Humans; Psychotic Disorders; Risk; Serine

1985
Metabolism of an ingested serine load in psychotic and nonpsychotic subjects.
    Biological psychiatry, 1985, Volume: 20, Issue:1

    Topics: Age Factors; Glycine; Glycine Hydroxymethyltransferase; Humans; Leucine; Metabolic Clearance Rate; P

1985
chemdatabank.com